HealthCor Management’s Henry Schein HSIC Stock Holding History

HealthCor Management’s Portfolio HSIC Stock Details HSIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-248,920	Closed	-$16.4M	–	40
2022 Q3	$16.4M	Hold	248,920	–	–	2.05%	21
2022 Q2	$19.1M	Sell	248,920 -6,310	-2%	-$529K	1.92%	21
2022 Q1	$22.3M	Buy	255,230 +127,620	+100%	+$10.4M	1.48%	31
2021 Q4	$9.89M	Buy	+127,610	New	+$9.75M	0.54%	41

Other funds holding HSIC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HealthCor Management's HSIC Position: Q4 2022 in Review

HealthCor Management sold out of Henry Schein (HSIC) in Q4 2022, closing a stake of 248,920 shares — an estimated $16.4M sold.

HealthCor Management first reported a position in HSIC in Q4 2021 and held it in 4 quarters. The position peaked at $22.3M in Q1 2022. 587 funds tracked by Wall St. Rank hold HSIC as of Q4 2022.

HealthCor Management reported no remaining Henry Schein position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 248,920 Henry Schein shares in Q4 2022, an estimated $16.4M.
HealthCor Management first reported a position in Henry Schein in Q4 2021 and held it in 4 quarters.
HealthCor Management's Henry Schein position peaked at $22.3M in Q1 2022.
587 funds tracked by Wall St. Rank held Henry Schein as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.